CIK 0001576280 · Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454139254
- Phone
- 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,739,100
- in 9 filings, $213K under 10b5-1 plans
Net −$9,739,100. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-15 | Freeman Chris Chief Commercial Officer | Option exercise | +1,402 | 61,695 | ||
| 2026-06-15 | Freeman Chris Chief Commercial Officer | Shares withheld for taxes | −594 | $129.82 | $77K | 61,101 |
| 2026-06-15 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,402 | 0 | ||
| 2026-06-15 | Saia John G. Chief Legal Officer | Option exercise | +1,020 | 36,970 | ||
| 2026-06-15 | Saia John G. Chief Legal Officer | Shares withheld for taxes | −535 | $129.82 | $69K | 36,435 |
| 2026-06-15 | Saia John G. Chief Legal Officer | Option exercise · Restricted Stock Units | −1,020 | 0 | ||
| 2026-06-15 | Bell Michael Brian Chief Financial Officer | Option exercise | +2,039 | 49,548 | ||
| 2026-06-15 | Bell Michael Brian Chief Financial Officer | Shares withheld for taxes | −1,096 | $129.82 | $142K | 48,452 |
| 2026-06-15 | Bell Michael Brian Chief Financial Officer | Option exercise · Restricted Stock Units | −2,039 | 0 | ||
| 2026-06-11 | Kalia Kumud Chief Information Officer | Sale | −3,418 | $130.24 | $445K | 41,090 |
| 2026-06-10 | Kalia Kumud Chief Information Officer | Sale | −600 | $130.86 | $79K | 40,814 |
| 2026-06-10 | Kalia Kumud Chief Information Officer | Sale | −5,000 | $130.41 | $652K | 44,508 |
| 2026-06-05 | Eltoukhy Helmy Co-Chief Executive Officer | Sale | −49,716 | $125.57 | $6.2M | 2,063,203 |
| 2026-06-05 | Eltoukhy Helmy Co-Chief Executive Officer | Sale | −33,843 | $126.33 | $4.3M | 2,029,360 |
| 2026-06-05 | Eltoukhy Helmy Co-Chief Executive Officer | Sale | −1,100 | $127.02 | $140K | 2,028,260 |
| 2026-06-05 | Eltoukhy Helmy Co-Chief Executive Officer | Sale | −13,787 | $128.25 | $1.8M | 2,014,473 |
| 2026-06-05 | Eltoukhy Helmy Co-Chief Executive Officer | Sale | −554 | $130.21 | $72K | 2,013,919 |
| 2026-06-05 | Eltoukhy Helmy Co-Chief Executive Officer | Sale | −900 | $131.78 | $119K | 2,013,019 |
| 2026-06-05 | Eltoukhy Helmy Co-Chief Executive Officer | Sale | −100 | $132.55 | $13K | 2,012,919 |
| 2026-06-05 | Bell Michael Brian Chief Financial Officer | Sale | −2,000 | $128.62 | $257K | 47,509 |
Page 14 of 22 · 421 trades